Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Change in Account Payables of -$2.9 million for Q1 2026, down 110.39% year-over-year from $28.3 million in Q1 2025, and down 490.7% quarter-over-quarter from $753000.0 in Q4 2025.
Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Account Payables history runs 14 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 110.39% year-over-year to -$2.9 million; the TTM figure through Mar 2026 stood at -$4.2 million (down 108.96% YoY), while the FY2025 annual figure was $45.6 million, up 279.62% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.9 million, down from $753000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $28.3 million in Q1 2025, with the low at -$9.0 million in Q4 2022.
- The 5-year median for Change in Account Payables is $1.3 million (2024), against an average of $2.4 million.
- Peak annual rise in Change in Account Payables reached 1409.44% in 2022, while the deepest fall reached 1188.52% in 2022.
- Phibro Animal Health's Change in Account Payables stood at -$9.0 million in 2022, then soared by 176.95% to $6.9 million in 2023, then surged by 91.74% to $13.3 million in 2024, then sank by 94.34% to $753000.0 in 2025, then slumped by 490.7% to -$2.9 million in 2026.
- Business Quant data shows PAHC's Change in Account Payables at -$2.9 million in Q1 2026, $753000.0 in Q4 2025, and -$4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | -2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94 Mn |
| Mar 31, 2026 | -2.94 Mn |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | -4.63 Mn |
| Sep 30, 2025 | -4.63 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Dec 31, 2023 | 6.94 Mn |